JF
CSTL icon

Jump Financial’s Castle Biosciences CSTL Stock Holding History

Jump Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$302K Buy
12,300
+6,800
+124% +$223K ﹤0.01% 1480
2025
Q4 		$214K Buy
+5,500
New +$177K ﹤0.01% 1714
2025
Q3 		– Sell
-21,858
Closed -$446K – 1847
2025
Q2 		$446K Buy
+21,858
New +$405K ﹤0.01% 1270
2025
Q1 		– Sell
-11,400
Closed -$304K – 1654
2024
Q4 		$304K Sell
11,400
-24,736
-68% -$753K 0.01% 1297
2024
Q3 		$1.03M Buy
+36,136
New +$920K 0.02% 785
2024
Q1 		– Sell
-20,436
Closed -$441K – 1958
2023
Q4 		$441K Sell
20,436
-3,564
-15% -$62.7K 0.01% 1144
2023
Q3 		$405K Buy
24,000
+4,300
+22% +$75.2K 0.02% 1127
2023
Q2 		$270K Buy
19,700
+2,300
+13% +$46.6K 0.01% 1364
2023
Q1 		$395K Sell
17,400
-1,900
-10% -$46.4K 0.02% 996
2022
Q4 		$454K Sell
19,300
-1,006
-5% -$23.3K 0.02% 819
2022
Q3 		$530K Buy
20,306
+2,706
+15% +$75.9K 0.02% 879
2022
Q2 		$386K Buy
17,600
+1,398
+9% +$32.5K 0.02% 958
2022
Q1 		$727K Sell
16,202
-14,042
-46% -$580K 0.03% 653
2021
Q4 		$1.3M Buy
30,244
+24,544
+431% +$1.28M 0.08% 307
2021
Q3 		$379K Sell
5,700
-1,100
-16% -$77.4K 0.03% 566
2021
Q2 		$499K Buy
+6,800
New +$449K 0.05% 476
2020
Q4 		– Sell
-3,970
Closed -$204K – 982
2020
Q3 		$204K Buy
+3,970
New +$177K 0.04% 634

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Financial's CSTL Position: Q1 2026 in Review

Jump Financial increased its Castle Biosciences (CSTL) stake by 124% in Q1 2026, buying an estimated $223K and bringing the position to 12,300 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Jump Financial first reported a position in CSTL in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.3M in Q4 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Jump Financial held 12,300 shares of Castle Biosciences worth $302K as of Q1 2026.
  • Jump Financial bought 6,800 Castle Biosciences shares in Q1 2026, an estimated $223K.
  • Castle Biosciences made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1480 holding.
  • Jump Financial first reported a position in Castle Biosciences in Q3 2020 and has held it in 17 quarters since.
  • Jump Financial's Castle Biosciences position peaked at $1.3M in Q4 2021.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.